Lyell Immunopharma, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US55083R1041
USD
25.46
4.65 (22.35%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
382.82
654.95
833.25
929.79
-292.53
-111.11
Shareholder's Funds
382.82
654.95
833.25
929.79
-292.53
-111.11
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
7.97
6.27
4.53
1.17
1,014.58
519.51
Secured Loans
7.97
6.27
4.53
1.17
1,014.58
519.51
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
54.25
60.56
67.28
150.88
140.56
125.53
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
54.25
60.56
67.28
150.88
1,151.52
644.69
Current Liabilities
Trade Payables
5.37
4.82
3.92
3.21
9.40
2.84
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
53.79
34.52
37.03
46.74
49.28
22.05
Total Liabilities
490.86
750.03
937.56
1,127.41
908.28
555.63
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
143.62
193.96
198.65
181.15
129.16
44.96
Less: Accumulated Depreciation
70.68
51.65
32.38
14.51
5.10
1.26
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
72.94
142.32
166.26
166.64
124.06
43.70
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
33.70
48.79
115.32
331.00
163.91
70.78
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
4.62
4.24
4.68
3.48
2.77
0.89
Total Non-Current Assets
111.26
195.34
286.27
501.12
290.73
115.37
Current Assets Loans & Advances
Current Investments
264.93
400.58
516.60
320.97
472.21
339.38
Inventories
0.00
0.00
0.00
0.00
0.00
0.00
Sundry Debtors
0.00
0.00
0.00
0.00
0.00
0.00
Cash and Bank
105.60
145.65
123.55
293.83
140.41
96.67
Other Current Assets
370.53
546.22
640.15
614.79
612.62
436.05
Short Term Loans and Advances
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Assets
379.59
554.69
651.29
626.29
617.55
440.26
Net Current Assets (Including Current Investments)
325.81
520.17
614.27
579.55
568.26
418.21
Total Current Assets Excluding Current Investments
379.59
554.69
651.29
626.29
617.55
440.26
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
490.86
750.03
937.56
1,127.41
908.28
555.63
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
7.97
6.27
4.53
1.17
1,014.58
519.51
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Compare Balance Sheet Results of Lyell Immunopharma, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
382.82
459.22
-76.40
-16.64%
Shareholder's Funds
382.82
459.22
-76.40
-16.64%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
7.97
1.00
6.97
697.00%
Secured Loans
7.97
1.00
6.97
697.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
0
0.00
0.00%
Other Long Term Liabilities
54.25
3.74
50.51
1,350.53%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
54.25
3.74
50.51
1,350.53%
Current Liabilities
Trade Payables
5.37
5.58
-0.21
-3.76%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
53.79
23.86
29.93
125.44%
Total Liabilities
490.86
486.82
4.04
0.83%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
143.62
15.76
127.86
811.29%
Less: Accumulated Depreciation
70.68
4.68
66.00
1,410.26%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
72.94
11.07
61.87
558.90%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
33.70
0
33.70
0.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
4.62
0.26
4.36
1,676.92%
Total Non-Current Assets
111.26
11.33
99.93
881.99%
Current Assets Loans & Advances
Current Investments
264.93
428.50
-163.57
-38.17%
Inventories
0
0
0.00
0.00%
Sundry Debtors
0
0
0.00
0.00%
Cash and Bank
105.60
41.67
63.93
153.42%
Other Current Assets
370.53
470.17
-99.64
-21.19%
Short Term Loans and Advances
0
0
0.00
0.00%
Total Current Assets
379.59
475.48
-95.89
-20.17%
Net Current Assets (Including Current Investments)
325.81
451.62
-125.81
-27.86%
Total Current Assets Excluding Current Investments
379.59
475.48
-95.89
-20.17%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
490.86
486.82
4.04
0.83%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
7.97
1.00
6.97
697.00%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Investments
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period